title: Matters of the heart: the case of TNFalpha-targeting drugs.
authors.affiliation: Internal Medicine and Rheumatology, N. Melli Hospital, San Pietro Vernotico, Brindisi, Italy. f.cacciapaglia@unicampus.it
authors.forename: Fabio
authors.initials: F
authors.lastname: Cacciapaglia
authors.forename: Pierantonio
authors.initials: P
authors.lastname: Menna
authors.forename: Luca
authors.initials: L
authors.lastname: Navarini
authors.forename: Antonella
authors.initials: A
authors.lastname: Afeltra
authors.forename: Emanuela
authors.initials: E
authors.lastname: Salvatorelli
authors.forename: Giorgio
authors.initials: G
authors.lastname: Minotti
mesh_terms: D000818:Animals; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D002316:Cardiotonic Agents / Q000037:antagonists & inhibitors / Q000276:immunology / Q000378:metabolism / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects* / Q000502:physiology / Q000503:physiopathology; D006331:Heart Diseases / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D051379:Mice; D058990:Molecular Targeted Therapy / Q000009:adverse effects; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism*
chemical_list: D002316:Cardiotonic Agents; D014409:Tumor Necrosis Factor-alpha